Roles of humoral and neural factors in angiogenesis and lymphangiogenesis in pathological conditions and their significance in molecular targeting therapy

病理条件下体液和神经因子在血管生成和淋巴管生成中的作用及其在分子靶向治疗中的意义

基本信息

  • 批准号:
    15390084
  • 负责人:
  • 金额:
    $ 8.26万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2006
  • 项目状态:
    已结题

项目摘要

Angiogenesis is also a critical step for development and metastasis of cancers. Proinflammatory mediators, such as PGs may have cell-autonomous effects on tumor cells in autocrine fashion, however, our results from tumor implantation models in knockout mice which lack the host receptor signaling clarified that host stromal signaling of a PGE_2 receptor, EP3 has a crucial role in tumor-associated angiogenesis through the induction of proaniogenic growth factors, and exhibited the landscaping effects on tumor cells. An EP3 antagonist inhibited tumor-associated angiogenesis in wild type mice, but not in EP3 knockout mice, suggesting that host EP3 receptor signaling is important in prevention of tumor-associated angiogenesis. Further, bone marrow transplantation experiment revealed that recruitment of bone marrow cells which express EP3 receptor is critical for angiogenesis in vivo. Relevant PGE2 is generated through the actions of COX-2 and an inducible PGE synthase, mPGES-1. Impressive p … More henotypes of mPGES-1 knockout mice implanted with tumor cells are reduced tumor growth and angiogenesis. Tumor-associated lymphangiogenesis was also suppressed with a COX-2 inhibitor. Thus, control of EP receptor signaling as well as recruitment of EP receptor expressing cells in the tumor microenvironment is likely to be a novel therapeutic approach against malignant solid tumors.Calcitonin gene-related peptide (CGRP) is a 37-amino acid neuropeptide produced by tissue-specific alternative splicing of the primary transcript of the calcitonin/CGRP gene. CGRP is widely distributed in the central and peripheral nervous systems and exhibits numerous biological activities in mammals. Tumor growth was significantly reduced in the sites of sensory nerve denervation. When a CGRP antagonist, CGRP8-37 was given, tumor growth was suppressed compared with vehicle infusion. In CGRP knockout mice, the tumor growth and tumor-associated angiogenesis were significantly reduced compared with wild type mice. In LLC bearing wild type mice, CGRP precursor mRNA levels in dorsal root ganglion were increased compared with non-treated mice. This increase was abolished by sensory nerve denervations. Further, we found that ulcer healing was significantly delayed in CGRP knockout mice with reductions in angiogenesis and VEGF expression. In co-culture system using HUVEC and fiboblasts, CGRP increased tube formation of endothelial cells. These results suggested that CGRP release from sensory nerves stimulated during tumor development and ulcer healing facilitates angiogenesis, and that CGRP may become a target of new treatment for cancers or gastrointestinal mucosal injury. Less
血管生成也是癌症发展和转移的关键步骤。前列腺素等促炎介质可能以自分泌的方式对肿瘤细胞具有细胞自主性作用,然而,我们在缺乏宿主受体信号转导的基因敲除小鼠的肿瘤移植模型中的结果阐明了宿主间质PGE_2受体EP 3信号转导通过诱导促阴离子生长因子在肿瘤相关血管生成中起关键作用,并对肿瘤细胞表现出美化作用。在野生型小鼠中,EP 3拮抗剂抑制肿瘤相关的血管生成,但在EP 3敲除小鼠中不抑制,这表明宿主EP 3受体信号传导在预防肿瘤相关的血管生成中是重要的。此外,骨髓移植实验表明,表达EP 3受体的骨髓细胞的募集对于体内血管生成是至关重要的。通过考克斯-2和诱导型PGE合酶mPGES-1的作用产生相关的PGE 2。令人印象深刻的P ...更多信息 植入肿瘤细胞的mPGES-1敲除小鼠的表型是减少的肿瘤生长和血管生成。肿瘤相关的淋巴管生成也被考克斯-2抑制剂抑制。因此,控制EP受体信号传导以及在肿瘤微环境中募集EP受体表达细胞可能是一种新的治疗恶性实体瘤的方法。降钙素基因相关肽(CGRP)是降钙素/CGRP基因的初级转录本通过组织特异性选择性剪接产生的37个氨基酸的神经肽。CGRP广泛分布于哺乳动物的中枢和外周神经系统,并表现出多种生物学活性。在感觉神经去神经支配的部位,肿瘤生长显著减少。当给予CGRP拮抗剂CGRP 8 -37时,与载体输注相比,肿瘤生长受到抑制。在CGRP基因敲除小鼠中,与野生型小鼠相比,肿瘤生长和肿瘤相关的血管生成显著减少。在携带LLC的野生型小鼠中,背根神经节中的CGRP前体mRNA水平与未处理的小鼠相比增加。这种增加被取消的感觉神经去神经。此外,我们发现CGRP基因敲除小鼠的溃疡愈合显著延迟,血管生成和VEGF表达减少。在HUVEC与成纤维细胞共培养体系中,CGRP可促进内皮细胞管腔形成。这些结果表明,CGRP从刺激感觉神经在肿瘤的发展和溃疡愈合促进血管生成,CGRP可能成为一个新的治疗癌症或胃肠道粘膜损伤的目标。少

项目成果

期刊论文数量(31)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice.
  • DOI:
    10.1172/jci21446
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Takuya Kobayashi;Y. Tahara;Mayumi Matsumoto;M. Iguchi;H. Sano;T. Murayama;H. Arai;H. Oida;
  • 通讯作者:
    Takuya Kobayashi;Y. Tahara;Mayumi Matsumoto;M. Iguchi;H. Sano;T. Murayama;H. Arai;H. Oida;
癌と血管新生の分子物理学
癌症和血管生成的分子物理学
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Katori M;Majima M.;馬嶋 正隆
  • 通讯作者:
    馬嶋 正隆
Calcitonin gene-related peptide released by capsaicin suppresses myoelectrical activity of gastric smooth muscle.
辣椒素释放的降钙素基因相关肽抑制胃平滑肌的肌电活动。
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Mizuguchi S;Ohno T;Hattori Y;Kamata K;Arai K;Saeki T;Saigenji K;Hayashi I;Kuribayashi Y;Majima M
  • 通讯作者:
    Majima M
Effect of MKC-733, a 5-HT receptor partial agonist, on bowel motility and symptoms in subjects with constipation : an exploratory study.
MKC-733(一种 5-HT 受体部分激动剂)对便秘受试者肠蠕动和症状的影响:一项探索性研究。
Host stromal bradykinin B2 receptor signaling facilitates tumor-associated angiogenesis and tumor growth
  • DOI:
    10.1158/0008-5472.can-03-3589
  • 发表时间:
    2004-08-01
  • 期刊:
  • 影响因子:
    11.2
  • 作者:
    Ikeda, Y;Hayashi, I;Majima, M
  • 通讯作者:
    Majima, M
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MAJIMA Masataka其他文献

MAJIMA Masataka的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MAJIMA Masataka', 18)}}的其他基金

Lymphangiogenesis as a regulator of fluid homeostasis in pathological settings
淋巴管生成作为病理环境中液体稳态的调节剂
  • 批准号:
    24659119
  • 财政年份:
    2012
  • 资助金额:
    $ 8.26万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Roles of VEGF type 1 receptor signaling in pathologicalangiogenesis/lymphangiogenesis
VEGF 1 型受体信号传导在病理性血管生成/淋巴管生成中的作用
  • 批准号:
    21390072
  • 财政年份:
    2009
  • 资助金额:
    $ 8.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Roles of inducible cyclooxvgenase-2 in angiogenesis and its significance of therapeutic targets
诱导型环氧合酶2在血管生成中的作用及其治疗靶点的意义
  • 批准号:
    12470529
  • 财政年份:
    2000
  • 资助金额:
    $ 8.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Preventive roles of renal Kallikrein-kinin system for hypertension
肾激肽释放酶-激肽系统对高血压的预防作用
  • 批准号:
    07672472
  • 财政年份:
    1995
  • 资助金额:
    $ 8.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a novel anti-hypertensive agent acting through the inhibition of urinary kininase.
开发一种通过抑制尿激酶发挥作用的新型抗高血压药。
  • 批准号:
    05671904
  • 财政年份:
    1993
  • 资助金额:
    $ 8.26万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

LYVE-1(+)Mac-1通过NF-κB途径调节宫颈癌淋巴管新生机制的研究
  • 批准号:
    81072134
  • 批准年份:
    2010
  • 资助金额:
    37.0 万元
  • 项目类别:
    面上项目

相似海外基金

Novel therapies for obesity- or diabetes-related lymphatic dysfunction
肥胖或糖尿病相关淋巴功能障碍的新疗法
  • 批准号:
    10602589
  • 财政年份:
    2023
  • 资助金额:
    $ 8.26万
  • 项目类别:
The Role of lymphatic endothelium in the developing thymus
淋巴内皮在胸腺发育中的作用
  • 批准号:
    10737333
  • 财政年份:
    2023
  • 资助金额:
    $ 8.26万
  • 项目类别:
Anti-nucleolin aptamer AS1411: Applications in Kaposi's Sarcoma Associated Herpes Virus (KSHV) biology
抗核仁素适体 AS1411:在卡波西肉瘤相关疱疹病毒 (KSHV) 生物学中的应用
  • 批准号:
    10619191
  • 财政年份:
    2023
  • 资助金额:
    $ 8.26万
  • 项目类别:
Discerning mechanisms of semaphorin 7A-mediated tumor progression via immunoevasion
通过免疫逃避识别信号蛋白 7A 介导的肿瘤进展的机制
  • 批准号:
    10744585
  • 财政年份:
    2023
  • 资助金额:
    $ 8.26万
  • 项目类别:
Tissue-Engineered Models of Lymphatic Drainage in Breast Cancer
乳腺癌淋巴引流的组织工程模型
  • 批准号:
    10637169
  • 财政年份:
    2023
  • 资助金额:
    $ 8.26万
  • 项目类别:
Discovery of PPI inhibitors for the FAK FAT domain
发现 FAK FAT 结构域的 PPI 抑制剂
  • 批准号:
    10576504
  • 财政年份:
    2022
  • 资助金额:
    $ 8.26万
  • 项目类别:
Role of ACER2 in cancer chemoresistance and metastasis
ACER2在癌症化疗耐药和转移中的作用
  • 批准号:
    10650378
  • 财政年份:
    2022
  • 资助金额:
    $ 8.26万
  • 项目类别:
Discerning the role of semaphorin 7a in mammary tumor growth and anti-tumor immunity
识别信号蛋白 7a 在乳腺肿瘤生长和抗肿瘤免疫中的作用
  • 批准号:
    10739289
  • 财政年份:
    2022
  • 资助金额:
    $ 8.26万
  • 项目类别:
Discerning the role of semaphorin 7a in mammary tumor growth and anti-tumor immunity
识别信号蛋白 7a 在乳腺肿瘤生长和抗肿瘤免疫中的作用
  • 批准号:
    10537926
  • 财政年份:
    2022
  • 资助金额:
    $ 8.26万
  • 项目类别:
Exosomes in HNSCC Progression
外泌体在 HNSCC 进展中的作用
  • 批准号:
    10614381
  • 财政年份:
    2021
  • 资助金额:
    $ 8.26万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了